当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Journal of Hematology & Oncology杂志
Journal of Hematology & Oncology
基本信息
期刊名称 Journal of Hematology & Oncology
J HEMATOL ONCOL
期刊ISSN 1756-8722
期刊官方网站 https://jhoonline.biomedcentral.com/
是否OA
出版商 BioMed Central Ltd.
出版周期 Irregular
始发年份 2008
年文章数 125
最新影响因子 28.5(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学1区 HEMATOLOGY 血液学2区
ONCOLOGY 肿瘤学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 7.44 2.960 1.593
Medicine
Hematology
3 / 122 97%
Biochemistry, Genetics and Molecular Biology
Cancer Research
11 / 191 94%
Medicine
Oncology
13 / 321 96%
Biochemistry, Genetics and Molecular Biology
Molecular Biology
23 / 375 94%
补充信息
自引率 9.00%
H-index 46
SCI收录状况 Science Citation Index Expanded
官方审稿时间
Speed
37 days to first decision for reviewed manuscripts only
41 days to first decision for all manuscripts
79 days from submission to acceptance
15 days from acceptance to publication
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-8722%5BISSN%5D
投稿指南
期刊投稿网址 https://jhoonline.biomedcentral.com/submission-guidelines
收稿范围

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology

收录体裁
Research article
Review
Case report
Commentary
Letter to the Editor
Rapid communication
Research highlight
Short report
投稿指南 https://jhoonline.biomedcentral.com/submission-guidelines
投稿模板 https://jhoonline.biomedcentral.com/submission-guidelines/preparing-your-manuscript
参考文献格式 https://jhoonline.biomedcentral.com/submission-guidelines/preparing-your-manuscript
编辑信息

Editor-in-Chief
Prof Delong Liu, New York Medical College, USA

Deputy Editor-in-Chief
Prof Weijing Sun, University of Kansas, USA
Prof Kongming Wu, Tongji Medical College of Huazhong University of Science and Technology, China

Associate Editors
Prof Alan Burnett, University of Wales College of Medicine, UK
Prof Franco Cavalli, Oncology Institute of Southern Switzerland, Switzerland
Prof Guo-Qiang Chen, Shanghai Jiaotong University School of Medicine, China
Prof Edward Chu, University of Pittsburgh Cancer Institute, USA
Prof Jorge Cortes, MD Anderson Cancer Center, USA
Prof Weidong Han, Chinese PLA General Hospital, China
Dr Chung-Tsen Hsueh, Loma Linda University, USA
Prof Xiao-Jun Huang, Peking University People's Hospital, China
Dr Mary Laughlin, Case Western Reserve University, USA
Dr Tianhong Li, UC Davis Comprehensive Cancer Center, USA
Prof Zihai Li, Medical University of South Carolina, USA
Prof Lucio Luzzatto, Muhimbili University of Health and Allied Sciences, Tanzania
Prof Jun Ma, Harbin Institute of Hematology & Oncology, China
Dr Peter Maslak, Memorial Sloan-Kettering Cancer Center, USA
Dr William Oh, Icahn School of Medicine at Mount Sinai, USA
Prof Shukui Qin, Nanjing Bayi Hospital, China
Dr Azra Raza, Columbia University Medical Center, USA
Prof Ruibao Ren, Brandeis University, USA
Dr Karen Seiter, New York Medical College, USA
Prof Martin Tallman, Memorial Sloan-Kettering Cancer Center, USA
Prof Stephen Tsang, Columbia University, USA
Dr Jianxiang Wang, Chinese Academy of Medical Sciences, China
Prof Depei Wu, Jiangsu Institute of Hematology, China
Dr Timothy Yap, Royal Marsden Hospital, UK
Prof Jinming Yu, Shandong Cancer Hospital, China
Dr RuiRong Yuan, University of Medicine and Dentistry, USA

Editorial Board

Dr Tauseef Ahmed, New York Medical College, USA
Prof Frédéric Baron, University of Liege, Belgium
Dr Jo Caers, University Hospital Liège, Belgium
Dr Shundong Cang, Zhengzhou University, China
Prof Ying-Jun Chang, Peking University People's Hospital, China
Prof Yuanzhong Chen, Fujian Medical University, China
Prof Yue-Qin Chen, Sun Yat-sen University, China
Prof Jen-Wei Chiao, New York Medical College, USA
Prof Janice L Gabrilove, Mount Sinai School of Medicine, USA
Prof He Huang, The First Affiliated Hospital, Zhejiang University School of Medicine, China
Prof Sundar Jagannath, Mount Sinai Medical Center, USA
Dr Milind Javle, MD Anderson Cancer Center, USA
Dr Chunyan Ji, Shandong University, China
Prof Yangfu Jiang, Sichuan University, China
Prof Yok-lam Kwong, Queen Mary Hospital, Hong Kong, China
Dr Ross L Levine, Memorial Sloan Kettering Cancer Center, USA
Prof Jin Li, Cancer Hospital Shanghai, China
Prof Peng Li, Chinese Academy of Sciences, China
Prof Yangqiu Li, Ji Nan University Guangzhou, China
Prof Qi-Fa Liu, Nanfang Hospital, Southern Medical University, China
Prof Janice Lu, University of California, Los Angeles, USA
Dr Sylvain Meloche, Institut de Recherche en Immunologie et Cancérologie, Canada
Dr Owen A O'Connor, Herbert Irving Comprehensive Cancer Center, USA
Dr Pier Paolo Pandolfi, Harvard Medical School, USA
Dr Fazlul Sarkar, Wayne State University School of Medicine, USA
Dr Nicholas Short, MD Anderson Cancer Center, USA
Prof Yongping Song, Zhengzhou University, China
Dr Simona Soverini, University of Bologna
Dr Amit Verma, Albert Einstein College of Medicine, USA
Dr Srdan Verstovsek, MD Anderson Cancer Center, USA
Prof Justin Jong-Leong Wong, Centenary Institute, Australia
Dr Shenhong Wu, Stony Brook University Cancer Center, USA
Prof Mingzhi Zhi Zhang, First Affiliated Hospital of Zhengzhou University Medical School, China
Prof Xi Zhang, Xinqiao Hospital, China
Prof Yi Zhang, First Affiliated Hospital ofZhengzhou University, China
Dr Lei Zheng, Johns Hopkins University School of Medicine, USA
Prof Jun Zhu, Peking University Cancer Hospital & Institute, China


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug